ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Nurexone Biologic Inc

Nurexone Biologic Inc (NRX)

0.70
-0.03
(-4.11%)
Closed June 25 4:00PM

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)USD ($)USD ($)
Total Revenue 002k00000
Operating Income -39k-822k-21k-26k-15k-24k-4.43M-3.51M
Pre Tax Income -39k-821k-147k-85k-27k-166k-8.17M-3.64M
Net Income -39k-821k-136k-85k-27k-166k-8.17M-3.64M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.004-0.035-0.006-0.003-0.001-0.007-0.191-0.075
EBIT -39k-822k-21k5k40k-24k-4.49M-3.51M
EBITDA -39k-822k-21k-26k-15k-24k-4.41M-3.47M